Malformative Reno-Urinary Pathology in Patients with HIV Infection-Clinical and Therapeutic Implications

1. Wyatt CM, Winston JA, Malvestutto CD, Fishbein DA, Barash I, Cohen AJ, et al. Chronic kidney disease in HIV infection: an urban epidemic. AIDS. 2007 Oct 1;21(15):2101-3.10.1097/QAD.0b013e3282ef1bb417885301Search in Google Scholar

2. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004 Sep;66(3):1145-52.10.1111/j.1523-1755.2004.00865.x15327410Search in Google Scholar

3. Swanepoel CR, Atta MG, D’Agati VD, Estrella MM, Fogo AB, Naicker S, et al. Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2018 Mar;93(3):545-59.Search in Google Scholar

4. Streinu-Cercel A, Sandulescu O, Poiana C, Dorobantu M, Mircescu G, Lazureanu VE, et al. Consensus statement on the assessment of comorbidities in people living with HIV in Romania. Germs. 2019 Dec;9(4):198-210.10.18683/germs.2019.1178694265532042727Search in Google Scholar

5. Crum-Cianflone N, Ganesan A, Teneza-Mora N, Riddle M, Medina S, Barahona I, et al. Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS Patient Care STDS. 2010;24(6):353-6010.1089/apc.2009.0326293356120515419Search in Google Scholar

6. Campbell LJ, Ibrahim F, Fisher M, Holt SG, Hendry BM, Post FA. Spectrum of chronic kidney disease in HIV-infected patients. HIV Med. 2009 Jul;10(6):329-36.10.1111/j.1468-1293.2008.00691.x19226409Search in Google Scholar

7. Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis. 2008 Jun 1;197(11):1548-57.10.1086/587994255320918422458Search in Google Scholar

8. Morlat P, Vivot A, Vandenhende MA, Dauchy FA, Asselineau J, Deti E, et al. Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012. PLoS One. 2013;8(6):e66223.10.1371/journal.pone.0066223368043923776637Search in Google Scholar

9. Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS. 2012 Sep 24;26(15):1907-15.10.1097/QAD.0b013e328357f5ed353162822824630Search in Google Scholar

10. Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS. 2010 Jul 17;24(11):1667-7810.1097/QAD.0b013e328339fe5320523203Search in Google Scholar

11. Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, et al. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015 Mar;12(3):e1001809.10.1371/journal.pmed.1001809438041525826420Search in Google Scholar

12. Yombi JC, Pozniak A, Boffito M, Jones R, Khoo S, Levy J, et al. Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity. AIDS. 2014 Mar 13;28(5):621-32.10.1097/QAD.000000000000010324983540Search in Google Scholar

13. Milburn J, Jones R, Levy JB. Renal effects of novel antiretroviral drugs. Nephrol Dial Transplant. 2017 Mar 1;32(3):434-9.Search in Google Scholar

14. EACS European AIDS Clinical Society. Guidelines. Version 10.0 November 2019. 2019.Search in Google Scholar

15. Kirkpatrick JJ, Leslie SW. Horseshoe Kidney. StatPearls: StatPearls Publishing; 2018.Search in Google Scholar

16. Taghavi K, Kirkpatrick J, Mirjalili SA. The horseshoe kidney: Surgical anatomy and embryology. J Pediatr Urol. 2016 Oct;12(5):275-80.10.1016/j.jpurol.2016.04.03327324557Search in Google Scholar

17. Natsis K, Piagkou M, Skotsimara A, Protogerou V, Tsitouridis I, Skandalakis P. Horseshoe kidney: a review of anatomy and pathology. Surg Radiol Anat. 2014 Aug;36(6):517-26.10.1007/s00276-013-1229-724178305Search in Google Scholar

18. Glodny B, Petersen J, Hofmann KJ, Schenk C, Herwig R, Trieb T, et al. Kidney fusion anomalies revisited: clinical and radiological analysis of 209 cases of crossed fused ectopia and horseshoe kidney. BJU Int. 2009 Jan;103(2):224-35.10.1111/j.1464-410X.2008.07912.x18710445Search in Google Scholar

19. Neville H, Ritchey ML, Shamberger RC, Haase G, Perlman S, Yoshioka T. The occurrence of Wilms tumor in horseshoe kidneys: a report from the National Wilms Tumor Study Group (NWTSG). J Pediatr Surg. 2002 Aug;37(8):1134-7.10.1053/jpsu.2002.3445812149688Search in Google Scholar

20. Huang EY, Mascarenhas L, Mahour GH. Wilms’ tumor and horseshoe kidneys: a case report and review of the literature. J Pediatr Surg. 2004 Feb;39(2):207-12.10.1016/j.jpedsurg.2003.10.01914966742Search in Google Scholar

21. Pawar AS, Thongprayoon C, Cheungpasitporn W, Sakhuja A, Mao MA, Erickson SB. Incidence and characteristics of kidney stones in patients with horseshoe kidney: A systematic review and meta-analysis. Urol Ann. 2018 Jan-Mar;10(1):87-93.10.4103/UA.UA_76_17579146529416282Search in Google Scholar

22. Suwannakhan A, Meemon K. Horseshoe kidney with extrarenal calyces and malformed renal vessels. Eur J Anat. 2016;20:355-9.Search in Google Scholar

23. Al Otay A, Sarhan O, El-Tholoth HS, Alhelaly A, Al Akrash H, Al Ghanbar M, et al. Different managements of horseshoe kidney stones, any difference in the outcome? Urology annals. 2018 Jul-Sep;10(3):287-90.10.4103/UA.UA_116_17606060130089987Search in Google Scholar

24. Hamada Y, Nishijima T, Watanabe K, Komatsu H, Tsukada K, Teruya K, et al. High incidence of renal stones among HIV-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapy. Clin Infect Dis. 2012 Nov;55(9):1262-9.10.1093/cid/cis62122820542Search in Google Scholar

25. Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, et al. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. J Infect Dis. 2013 May 1;207(9):1359-69.10.1093/infdis/jit043361042423382571Search in Google Scholar

26. Perazella MA. Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy. Kidney Int. 2010 Dec;78(11):1060-3.10.1038/ki.2010.34421076445Search in Google Scholar

27. Waheed S, Attia D, Estrella MM, Zafar Y, Atta MG, Lucas GM, et al. Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series. Clin Kidney J. 2015 Aug;8(4):420-5.10.1093/ckj/sfv041451589626251709Search in Google Scholar

28. Gupta SK, Post FA, Arribas JR, Eron JJ, Jr., Wohl DA, Clarke AE, et al. Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials. Aids. 2019 Jul 15;33(9):1455-65.10.1097/QAD.0000000000002223663504330932951Search in Google Scholar